Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.24M Buy
52,737
+1,770
+3% +$65.8K ﹤0.01% 2000
2026
Q1
$1.8M Sell
50,967
-5,235
-9% -$230K ﹤0.01% 2088
2025
Q4
$2.75M Buy
56,202
+2,267
+4% +$95.2K ﹤0.01% 1748
2025
Q3
$2.6M Sell
53,935
-35,982
-40% -$1.36M ﹤0.01% 1640
2025
Q2
$2.75M Buy
89,917
+25,776
+40% +$693K ﹤0.01% 2001
2025
Q1
$1.71M Buy
64,141
+2,201
+4% +$65.9K ﹤0.01% 2069
2024
Q4
$2.08M Buy
61,940
+29,262
+90% +$1.29M ﹤0.01% 2023
2024
Q3
$1.47M Buy
+32,678
New +$1.1M ﹤0.01% 2200

Other funds holding HROW

UBS AM's HROW Position: Q2 2026 in Review

UBS AM increased its Harrow (HROW) stake by 3.5% in Q2 2026, buying an estimated $65.8K and bringing the position to 52,737 shares worth $2.24M. The position accounts for ﹤0.01% of the portfolio, ranked #2000.

UBS AM first reported a position in HROW in Q3 2024 and has held it in 8 quarters since. The position peaked at $2.75M in Q4 2025. 223 funds tracked by Wall St. Rank hold HROW as of Q2 2026.

  • UBS AM held 52,737 shares of Harrow worth $2.24M as of Q2 2026.
  • UBS AM bought 1,770 Harrow shares in Q2 2026, an estimated $65.8K.
  • Harrow made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #2000 holding.
  • UBS AM first reported a position in Harrow in Q3 2024 and has held it in 8 quarters since.
  • UBS AM's Harrow position peaked at $2.75M in Q4 2025.
  • 223 funds tracked by Wall St. Rank held Harrow as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.